Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

H. Gisslinger, C. Klade, P. Georgiev, D. Krochmalczyk, L. Gercheva-Kyuchukova, M. Egyed, V. Rossiev, P. Dulicek, A. Illes, H. Pylypenko, L. Sivcheva, J. Mayer, V. Yablokova, K. Krejcy, HC. Hasselbalch, R. Kralovics, JJ. Kiladjian,

. 2020 ; 4 (6) : e485. [pub] 20201020

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21001937

AOP Orphan Pharmaceuticals AG Vienna Austria

Cherkasy Regional Oncology Centre Regional Treatment and Diagnostics Haematology Centre Department of Hematology Cherkasy Ukraine

Department of Hematology Zealand University Hospital Roskilde University of Copenhagen Denmark

Department of Laboratory Medicine Medical University of Vienna Vienna Austria and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Vienna Austria

Kaposi MorCounty Teaching Hospital Department of Internal Medicine 2 Kaposvar Hungary

Medical University Vienna Department of Internal Medicine 1 Division of Haematology and Blood Coagulation Vienna Austria

Multiprofile Hospital for Active Treatment HristoBotev 1st Department of Internal Medicine Vratsa Bulgaria

Multiprofile Hospital for Active Treatment Sveta Marina Clinical Hematology Clinic Varna Bulgaria

Samara Kalinin Regional Clinical Hospital Samara Russia

Université de Paris CIC 1427 Inserm Paris France and Centre d'Investigations Cliniques AP HP Hospital Saint Louis Paris France

University Hospital Brno Clinic of Internal Medicine Hematology and Oncology Brno Czech Republic

University Hospital Hradec Kralove Department of Clinical Hematology Hradec Kralove Czech Republic

University Hospital in Krakow Teaching Unit of the Hematology Department Krakow Poland

University Multiprofile Hospital for Active Treatment Sveti Georgi Clinic of Hematology Medical University of Plovdiv Plovdiv Bulgaria

University of Debrecen Faculty of Medicine Department of Hematology Debrecen Hungary

Yaroslavl Regional Clinical Hospital Department of Hematology Yaroslavl Russia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21001937
003      
CZ-PrNML
005      
20210126092854.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HS9.0000000000000485 $2 doi
035    __
$a (PubMed)33134869
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gisslinger, Heinz $u Medical University Vienna, Department of Internal Medicine I, Division of Haematology and Blood Coagulation, Vienna, Austria.
245    10
$a Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups. / $c H. Gisslinger, C. Klade, P. Georgiev, D. Krochmalczyk, L. Gercheva-Kyuchukova, M. Egyed, V. Rossiev, P. Dulicek, A. Illes, H. Pylypenko, L. Sivcheva, J. Mayer, V. Yablokova, K. Krejcy, HC. Hasselbalch, R. Kralovics, JJ. Kiladjian,
655    _2
$a časopisecké články $7 D016428
700    1_
$a Klade, Christoph $u AOP Orphan Pharmaceuticals AG, Vienna, Austria.
700    1_
$a Georgiev, Pencho $u University Multiprofile Hospital for Active Treatment "Sveti Georgi", Clinic of Hematology, Medical University of Plovdiv, Plovdiv, Bulgaria.
700    1_
$a Krochmalczyk, Dorota $u University Hospital in Krakow, Teaching Unit of the Hematology Department, Krakow, Poland.
700    1_
$a Gercheva-Kyuchukova, Liana $u Multiprofile Hospital for Active Treatment "Sveta Marina", Clinical Hematology Clinic, Varna, Bulgaria.
700    1_
$a Egyed, Miklos $u Kaposi MorCounty Teaching Hospital, Department of Internal Medicine II, Kaposvar, Hungary.
700    1_
$a Rossiev, Viktor $u Samara Kalinin Regional Clinical Hospital, Samara, Russia.
700    1_
$a Dulicek, Petr $u University Hospital Hradec Kralove, Department of Clinical Hematology, Hradec Kralove, Czech Republic.
700    1_
$a Illes, Arpad $u University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary.
700    1_
$a Pylypenko, Halyna $u Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy, Ukraine.
700    1_
$a Sivcheva, Lylia $u Multiprofile Hospital for Active Treatment - HristoBotev, First Department of Internal Medicine, Vratsa, Bulgaria.
700    1_
$a Mayer, Jiri $u University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czech Republic.
700    1_
$a Yablokova, Vera $u Yaroslavl Regional Clinical Hospital, Department of Hematology, Yaroslavl, Russia.
700    1_
$a Krejcy, Kurt $u AOP Orphan Pharmaceuticals AG, Vienna, Austria.
700    1_
$a Hasselbalch, Hans C $u Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Denmark.
700    1_
$a Kralovics, Robert $u Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
700    1_
$a Kiladjian, Jean-Jacques $u Université de Paris, CIC 1427, Inserm, Paris, France and Centre d'Investigations Cliniques, AP-HP, Hospital Saint-Louis, Paris, France.
773    0_
$w MED00201259 $t HemaSphere $x 2572-9241 $g Roč. 4, č. 6 (2020), s. e485
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33134869 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210126092850 $b ABA008
999    __
$a ind $b bmc $g 1614081 $s 1122221
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 4 $c 6 $d e485 $e 20201020 $i 2572-9241 $m HemaSphere $n Hemasphere $x MED00201259
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace